Company / Income Tax
Anika Therapeutics, Inc. Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$672.0K
FY2025
5-year range
-$4.6M / $8.9M
FY2021-FY2025
Trend
-88.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Income Tax has fluctuated over the past 10 years, ranging from -$5M in FY2022 to $23M in FY2016.
Based on SEC 10-K filings.
$672,000 in FY2025 with a 5-year CAGR of -31.6%.
Improved from $7M to $672,000 over the past 2 years.
Income Tax over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -31.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -31.6%, indicating a declining trend.
- In FY2025, income tax decreased 88.9% year-over-year.
- Peak income tax was recorded in FY2016.
- Lowest income tax in the period was in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $672.0K | -88.9% |
| FY2024 | $6.1M | -8.1% |
| FY2023 | $6.6M | +242.1% |
| FY2022 | -$4.6M | -152.0% |
| FY2021 | $8.9M | +99.1% |
| FY2020 | $4.5M | -68.8% |
| FY2019 | $14.4M | -21.5% |
| FY2018 | $18.3M | +4.7% |
| FY2017 | $17.5M | -24.5% |
| FY2016 | $23.2M | +94.8% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026